News
The Manila Times on MSN56m
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugsPeople taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback